CANC Holdings List

As of Jul 2, 2024

No.	Symbol	Name	% Weight	Shares
1	REGN	Regeneron Pharmaceuticals, Inc.	5.98%	2,491
2	AZN.L	AstraZeneca PLC	5.52%	15,657
3	MRK	Merck & Co., Inc.	4.83%	16,477
4	4568.T	Daiichi Sankyo Co Ltd	3.92%	48,835
5	ARGX	argenx SE	3.64%	3,634
6	BPMC	Blueprint Medicines Corporation	3.42%	13,498
7	NTLA	Intellia Therapeutics, Inc.	3.40%	66,894
8	AMGN	Amgen Inc.	3.40%	4,761
9	EXEL	Exelixis, Inc.	3.19%	62,623
10	INCY	Incyte Corporation	3.10%	22,842
11	NOVN.SW	Novartis AG Registered Shares	2.94%	11,979
12	ILMN	Illumina, Inc.	2.94%	12,114
13	MREO	Mereo BioPharma Group plc	2.90%	365,635
14	4519.T	Chugai Pharmaceutical Co Ltd	2.83%	34,393
15	RVMD	Revolution Medicines, Inc.	2.77%	32,303
16	GILD	Gilead Sciences, Inc.	2.54%	16,169
17	CLDX	Celldex Therapeutics, Inc.	2.43%	28,535
18	LEGN	Legend Biotech Corporation	2.30%	22,392
19	GMAB	Genmab A/S	2.21%	38,554
20	CRSP	CRISPR Therapeutics AG	2.19%	17,936
21	MRNA	Moderna, Inc.	2.15%	8,005
22	AGIO	Agios Pharmaceuticals, Inc.	2.10%	21,745
23	EXAS	Exact Sciences Corporation	2.06%	20,742
24	GH	Guardant Health, Inc.	2.02%	30,402
25	BGNE	BeiGene, Ltd.	1.99%	6,031
26	SHL.DE	Siemens Healthineers AG Registered Shares	1.99%	15,014
27	LNTH	Lantheus Holdings, Inc.	1.74%	9,648
28	NUVL	Nuvalent, Inc.	1.65%	9,817
29	DAWN	Day One Biopharmaceuticals, Inc.	1.52%	49,033
30	MRUS	Merus N.V.	1.49%	12,241
31	CRBP	Corbus Pharmaceuticals Holdings, Inc.	1.38%	12,555
32	ACLX	Arcellx, Inc.	1.37%	11,162
33	SWTX	SpringWorks Therapeutics, Inc.	1.33%	15,490
34	RCUS	Arcus Biosciences, Inc.	1.16%	34,606
35	FXFXX	First American Treasury Obligs X	1.04%	451,074
36	ARVN	Arvinas, Inc.	0.97%	16,952
37	CGEM	Cullinan Oncology, Inc.	0.90%	24,023
38	TERN	Terns Pharmaceuticals, Inc.	0.90%	58,225
39	JANX	Janux Therapeutics, Inc.	0.88%	9,723
40	COGT	Cogent Biosciences, Inc.	0.83%	43,856
41	SDGR	Schrödinger, Inc.	0.83%	17,726
42	RLAY	Relay Therapeutics, Inc.	0.81%	54,605
43	IDYA	IDEAYA Biosciences, Inc.	0.79%	10,154
44	IMCR	Immunocore Holdings plc	0.76%	9,454
45	CGON	CG Oncology, Inc.	0.51%	7,039
46	FATE	Fate Therapeutics, Inc.	0.35%	47,468
47	GRAL	GRAIL, Inc. Common Stock When Issued	0.07%	2,017
48	n/a	DEPOSITS WITH BROKER FOR SHORT POSITIONS	0.05%	471,066,973
49	n/a	US DOLLARS	-0.04%	18,716

As of Jul 2, 2024